Omzet 2024 * | 60,47 mld. 56,2 mld. | Omzet 2025 * | 62,71 mld. 58,28 mld. | Marktkapitalisatie | 159 mld. 147 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,28 mld. 6,76 mld. | Nettowinst (verlies) 2025 * | 10,81 mld. 10,05 mld. | EV/omzet 2024 * | 3,6 x |
Nettoschuld 2024 * | 59,14 mld. 54,96 mld. | Nettoschuld 2025 * | 54,22 mld. 50,39 mld. | EV/omzet 2025 * | 3,39 x |
K/w-verhouding 2024 * |
20,6
x | K/w-verhouding 2025 * |
14,1
x | Werknemers | - |
Dividendrendement 2024 * |
5,97% | Dividendrendement 2025 * |
6,09% | Vrij verhandelbaar | 59,05% |
Recentste transcriptie over Pfizer Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01-01-93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02-05-22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 66 | 01-04-20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23-02-17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27-09-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 815 mld. | |
+44,05% | 641 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,57% | 242 mld. | |
+2,04% | 224 mld. | |
+13,31% | 218 mld. | |
+8,48% | 168 mld. |